	US 11,808,708 B2
	Method for maintaining the health of a diabetic patient by preventing the occurrence of diabetic ketoacidosis
Tom Meitz, Audubon, PA (US); and Frank Puglisi, East Norriton, PA (US)
Assigned to F.A.T. STATS LLC, East Norriton, PA (US)
Filed by F.A.T. Stats LLC, East Norriton, PA (US)
Filed on Aug. 6, 2021, as Appl. No. 17/395,916.
Claims priority of provisional application 63/064,716, filed on Aug. 12, 2020.
Prior Publication US 2022/0050057 A1, Feb. 17, 2022
Int. Cl. G01N 21/78 (2006.01); A61K 31/7034 (2006.01)

CPC G01N 21/78 (2013.01) [A61K 31/7034 (2013.01)]

18 Claims

1. A method of monitoring for the onset of diabetic ketoacidosis in a diabetic patient, the method comprising:

providing at least one test strip for identifying the presence of β-hydroxybutyrate in the diabetic patient's urine, wherein the diabetic patient is taking an SGLT2 inhibitor;

continuing the SGLT2 inhibitor as directed when β-hydroxybutyrate is not indicated on the at least one test strip; and

discontinuing the SGLT2 inhibitor upon indication of the presence of β-hydroxybutyrate in the diabetic patient's urine to prevent the onset of diabetic ketoacidosis.